References

Abidi P et al. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vase Biol 25.10 (2005): 2170-6.

Babbar OP et al. Effect of berberine chloride eye drops on clinically positive trachoma patients. Indian J Med Res 76 (Suppl) (1982): 83-8.

Birdsall T, Kelly G. Therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 2 (1997): 94-103.

Blumenthal M. The ABC Clinical Guide To Herbs. New York: Thieme 2003.

Blumenthal M et al. The Complete German Commission E monographs: Therapeutic Guide to Herbal Medicines. Austin, TX: The American Botanical Council 1998.

Bone K. A Clinical Guide to Blending Liquid Herbs. St Louis: Churchill Livingstone 2003.

British Herbal Medicine Association Scientific Committee. British Herbal Pharmacopoeia. Lane House, Cowling, UK: BHMA 1983.

Budzinski JW et al. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7.4 (2000): 273-82.

Cho BJ et al. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol Cells 20.3 (2005): 429-34.

Choudhry VP et al. Berberine in giardiasis. Indian Pediatr 9.3 (1972): 143-6.

Ckless K et al. Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J Pharm Pharmacol 47.12A (1995): 1029-31.

Eaker EY, Sninsky CA. Effect of berberine on myoelectric activity and transit of the small intestine in rats. Gastroenterology 96.6 (1989): 1506-13.

Fukuda K et al. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66.2 (1999): 227-33.

Gao CR et al. Experimental study on berberine raised insulin sensitivity in insulin resistance rat models. Zhongguo Zhong Xi Yi Jie He Za Zhi 17.3 (1997): 162-4.

Genest K, Hughs DW. Natural products in Canadian pharmaceuticals. II: Hydrastis canadensis. Can J Pharm Sei 4: 41; as cited in Mahady GB, Chadwick LR. 2001 Golden Seal (Hydrastis canadensis): Is there enough scientific evidence to support safety and efficacy? Nutr Clin Care 4.5 (1969): 243-9.

Glastonbury S. Scientific evaluation of the use of traditional herbal depuratives via modulation of ABC transporters. Aust J Med Herbalism 15.2 (2003): 34-8.

Gupte S. Use of berberine in treatment of giardiasis. Am J Dis Child 129.7 (1975): 866.

Ho NK. Traditional Chinese medicine and treatment of neonatal jaundice. Singapore Med J 37.6 (1996): 64551.

Hong Y et al. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am J Chin Med 30.4 (2002): 589-99.

Hong Y et al. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sei 72.22 (2003): 2499-507.

Huang WM et al. Beneficial effects of berberine on hemodynamics during acute ischemic left ventricular failure in dogs. Chin Med J (Engl) 105.12 (1992): 1014-19.

Hui KK et al. Interaction of berberine with human platelet alpha 2 adrenoceptors. Life Sei 49.4 (1991): 315-24.

Hwang BY et al. Antimicrobial constituents from goldenseal (the rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Med 69.7 (2003): 623-7. Goldenseal 641

Hwang JM et al. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol 80.2 (2006): 62-73.

Kang BY et al. Involvement of p38 mitogen-activated protein kinase in the induction of interleukin-12 p40 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid. Biochem Pharmacol 63.10 (2002): 1901-10.

Kettmann V et al. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Pharmazie 59.7 (2004): 548-51.

Khin-Maung U, Nwe Nwe W. Effect of berberine on enterotoxin-induced intestinal fluid accumulation in rats. J Diarrhoeal Dis Res 10.4 (1992): 201-4.

Khin-Maung U et al. Clinical trial of berberine in acute watery diarrhoea. BMJ (Clin Res Ed) 291.6509 (1985): 1601-5.

Khin-Maung U et al. Clinical trial of high-dose berberine and tetracycline in cholera. J Diarrhoeal Dis Res 5.3

Khosla PK et al. Berberine, a potential drug for trachoma. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 69 (1992): 147-65.

Kim TS et al. Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Thl response. Immunology 109.3 (2003): 407-14.

Kong W et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10.12 (2004): 1344-51.

Kuo CL et al. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203.2 (2004): 12737.

Kuo CL et al. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo 19.1 (2005): 247-52.

Lau CWet al. Cardiovascular actions of berberine. Cardiovasc Drug Rev 19.3 (2001): 234-44.

Leng SH et al. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 25.4 (2004): 496-502.

Letasiova S et al. Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett 239 (2006): 254-62.

Lin HL et al. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer 85.9 (1999): 1937-42.

Liu JC et al. The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. Pharmacology 59.6 (1999): 283-9.

Mahady GB, Chadwick LR. Golden Seal (Hydrastis canadensis): Is there enough scientific evidence to support safety and efficacy? Nutr Clin Care 4.5 (2001): 243-9.

Mahady GB et al. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis Canadensis. Phytother Res 17.3 (2003): 217-21.

Marinova EK et al. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 48.1 (2000): 9-16.

Marin-Neto JA et al. Cardiovascular effects of berberine in patients with severe congestive heart failure. 11.4

Mills S, Bone K. The Essential Guide to Herbal Safety. St Louis: Churchill Livingstone 2005.

Mohan M et al. Berberine in trachoma: A clinical trial. Indian J Ophthalmol 30.2: 69-75; as cited in Mahady GB, Chadwick LR. 2001, Golden Seal (Hydrastis canadensis): Is there enough scientific evidence to support safety and efficacy? Nutr Clin Care 4.5 (1982): 243-9.

Musumeci Ret al. Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. Int J Antimic rob Agents 22.1 (2003): 48-53.

Pan GY et al. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91.4 (2002): 1937.

Pan GY et al. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Goldenseal

Park KS et al. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans. J Antimicrob Chemother 43.5 (1999): 667-74.

Pengelly A. The Constituents of Medicinal Plants. Sydney: Allen & Unwin 2004.

PiscitelliSC et al. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34.2 (2002): 234-8.

Rabbani GH. Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins. Dan Med Bull 43.2 (1996): 173-85.

Rabbani GH et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 155.5 (1987): 979-84.

Rehman J et al. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis Canadensis. Immunol Lett 68.2-3 (1999): 391-5.

Sack RB, Froehlich JL. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 35.2 (1982): 471-5.

Scazzocchio F et al. Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. Planta Med 67.6 (2001): 561-4.

Stermitz FRet al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 51-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sei USA 97.4 (2000a): 1433-7.

Stermitz FRet al. S'-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. J Nat Prod 63.8 (2000b): 1146-9.

Sun D et al. Berberine sulfate blocks adherence of streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrob Agents Chemother 32 (9) (1998): 1370-4.

Swabb EA et al. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 241.3 (1981): G248-52.

Tai WP, Luo HS. [The inhibit effect of berberine on human colon cell line cyclooxygenase-2]. Zhonghua Nei Ke ZaZhi42.8 (2003): 558-60.

Wu X et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol 61.8 (2005): 567-72.

Yao M et al. A reproductive screening test of goldenseal. Birth Defects Res B Dev Re prod Toxicol 74.5 (2005): 399-404.

Yin J et al. Effects of berberine on glucose metabolism in vitro. Metabolism 51.11 (2002): 1439-43.

Yu HH et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food 8.4 (2005): 454-61.

Yuan J et al. Effect of berberine on transit time of human small intestine. Zhongguo Zhong Xi Yi Jie He Za Zhi 14.12 (1994): 718-20.

Zeng XH et al. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92.2 (2003): 173-6.

Zhang RX et al. Laboratory studies of berberine used alone and in combination with l,3-bis(2-chloroethyl)-l-nitrosourea to treat malignant brain tumors. Chin Med J (Engl) 103.8 (1990): 658-65.

Zhu B, Ahrens FA. Effect of berberine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin in jejunum of pigs. Am. J Vet Res 43.9 (1982): 1594-8.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment